Offer - Urjas Oil for just ₹ 1 X
Pregeb D 50/20 Capsule (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Pregeb D 50/20 Capsule (10) safe for pregnant women?
Pregeb D Capsule can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pregeb D Capsule right away. Take your doctor's advice before taking it again.
Is the use of Pregeb D 50/20 Capsule (10) safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Pregeb D Capsule. So it is adviced to consult the doctor before using it.
What is the effect of Pregeb D 50/20 Capsule (10) on the Kidneys?
Pregeb D Capsule has very mild side effects on the kidneys.
What is the effect of Pregeb D 50/20 Capsule (10) on the Liver?
Pregeb D Capsule is completely safe for the liver.
What is the effect of Pregeb D 50/20 Capsule (10) on the Heart?
There are no any side effects of Pregeb D Capsule for the heart.
Pregeb D 50/20 Capsule (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Pregeb D 50/20 Capsule (10) unless your doctor advises you to do so -
Is this Pregeb D 50/20 Capsule (10) habit forming or addictive?
No, there is no any evidence that Pregeb D 50/20 Capsule (10) is addictive.
Interaction between Food and Pregeb D 50/20 Capsule (10)
Taking Pregeb D 50/20 Capsule (10) with food does not harm your health.
Interaction between Alcohol and Pregeb D 50/20 Capsule (10)
Consult your doctor before consuming alcohol while taking Pregeb D 50/20 Capsule (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 474-475
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 462
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cymbalta (duloxetine hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420